Accretion Pharmaceuticals Exempt From Q2 FY27 Corporate Governance Reporting
Accretion Pharmaceuticals Ltd 路 Others (Uncategorized) 路 10 Oct 2026, 9:17 pm
Accretion Pharmaceuticals Exempt From Q2 FY27 Corporate Governance Reporting Accretion Pharmaceuticals Limited confirmed the non-applicability of Regulation 27(2) of SEBI LODR Regulations, 2015, regarding the submission of quarterly Corporate Governance compliance reports for the quarter ended 30th Sep'26 (Q2 FY27). Under Regulation 15(2)(b), entities with securities listed on the SME Exchange (NSE Emerge Platform) are exempt from these governance provisions. The filing is supported by a certification from practicing company secretary firm M/s Sakhiya & Co., dated 9th Oct'26, confirming the regulatory exemption.
Original exchange filing (PDF)
More announcements from Accretion Pharmaceuticals Ltd
- Accretion Pharmaceuticals Limited has informed the Exchange about General Updates 路 16 Nov 2026
- Accretion Pharmaceuticals Limited has informed the Exchange about Investor Presentation 路 03 Nov 2026
- Accretion Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 02 Nov 2026
- Accretion Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 31, 2026, titled "Company Reports 25.83% Revenue Growth and 72.63% PAT Growth in H1 FY27 and Strong EBITDA Growth of 72.28%; EBITDA Margin Improves to 22.48%". 路 31 Oct 2026
- Accretion Pharmaceuticals Limited has submitted to the Exchange, the unaudited financial results for the half year ended September 30, 2026. 路 31 Oct 2026
- Accretion Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 31-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 31 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 31 Oct 2026
- Accretion Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has submitted the Exchange a copy of Srutinizers report. 路 12 Oct 2026
